Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Pharma Insights

Bringing Social Determinants of Health to Life to Optimize Health Outcomes in Patients With Chronic Conditions

02/15/2022

Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues address health care disparities in patients with chronic conditions, the roles of health systems and payers in closing these gaps, and a customizable SDOH toolbox to help stakeholders...

Elizabeth Oyekan, PharmD, FCSHP,...

02/15/2022

Journal of Clinical Pathways

Pharma Insights

Bending the Health Care Cost Curve and Changing the Drug Cost Paradigm in 2021 and Beyond

04/22/2021

Andrew Cournoyer , RPh, MBA;

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

The continued rise in health care spending continues to have a profound effect on the US economy and health care payers. The three complex drivers contributing to these increases include hospital, outpatient, and...

The...

04/22/2021

Journal of Clinical Pathways

Cancer Care in 2021 and Beyond: Catalytic Trends, Entrants, and Developments to Optimize Care During and Post Pandemic

02/22/2021

Elizabeth Oyekan , PharmD, FCSHP, CPHQ;

Health care has been traditionally immune to disruptive market forces until the COVID-19 global pandemic in 2020. This pandemic also highlighted the challenges and failings of our current health care system, creating...

Health...

02/22/2021

Journal of Clinical Pathways